Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

Background: For many patients, current treatments do not adequately resolve heartburn in nonerosive reflux disease (NERD). Objective: To compare vonoprazan and placebo with respect to the frequency and severity of heartburn in patients with NERD. Methods: This Phase III, double-blind, placebo-contro...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yoshikazu Kinoshita, MD, PhD, Yuuichi Sakurai, MPharm, Madoka Shiino, MPharm, Kentaro Kudou, MS, Akira Nishimura, BSc, MBA, Takuya Miyagi, MD, PhD, Katsuhiko Iwakiri, MD, PhD, Eiji Umegaki, MD, PhD, Kiyoshi Ashida, MD, PhD
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2016-01-01
Colecção:	Current Therapeutic Research
Assuntos:	gastroesophageal reflux heartburn NERD nonerosive gastroesophageal reflux disease potassium-competitive acid blockers vonoprazan
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S0011393X1630100X
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!